ReviewCurrent opinion in psychiatry2025
Gondal hormones and binge eating in females: developmental and etiologic insights from puberty to adulthood.
Review in Current opinion in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined Oral Contraceptive Use and Binge Eating.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewBinge eating (BE) is a core symptom of multiple eating disorders and disproportionately affects females during/after puberty. Gonadal hormones (estrogen, progesterone, testosterone) are sex-differentiated and have been posited as key biological contributors to BE risk. This review synthesizes recent findings from animal and human studies regarding gonadal hormone influences on the etiology BE in females during puberty and adulthood. RECENT
findingsEstrogen may exert organizational effects (i.e., long-lasting) during puberty that shape responsivity to activational effects (i.e., transient) of gonadal hormones on BE in late adolescence/adulthood. In adulthood, estradiol appears to be protective against BE, while progesterone antagonizes this effect. Emerging data also implicate testosterone as an additional hormonal risk factor for BE in women, particularly under conditions of lower estradiol. However, not all females exposed to these high-risk gonadal hormone milieus develop BE; behavior genetic studies provide empirical support for gene-by-hormone interactions in individual susceptibility. SUMMARY: Methodologically rigorous approaches (e.g., daily assessments, behavior genetics, hormone manipulation) have been critical in uncovering the complex etiologic influences of gonadal hormones on BE in females. Future research is needed to identify the specific neural circuits, genetic variants, and transcriptional pathways involved in these processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.